Annals of Oncology

1

Medical errors kill more than does breast cancer

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 1.63 MB

english, 2000

2

Agreement over paclitaxel reinforces BMS monopoly

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 1.87 MB

english, 2000

3

Amid growing inequalities, an invitation to act

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 1.74 MB

english, 2000

4

10.1023/a:1008398116335

Spataro, V.

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 77 KB

english, 2000

5

10.1023/a:1008358411251

Levy-Piedbois, C., Durand-Zaleski, I., Juhel, H., Schmitt, C., Bellanger, A., Piedbois, P.

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 491 KB

english, 2000

6

10.1023/a:1008325110921

Tondini, C., Balzarotti, M., Rampinelli, I., Valagussa, P., Luoni, M., De Paoli, A., Santoro, A., Bonadonna, G.

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 318 KB

english, 2000

7

10.1023/a:1008372404504

Sessa, C., Wanders, J., Roelvink, M., Dombernowsky, P., Nielsen, D., Morant, R., Drings, P., Wissel, P., Hanauske, A.-R.

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 505 KB

english, 2000

8

10.1023/a:1008382030802

Rijnders, B., Decramer, M.

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 2.26 MB

english, 2000

9

10.1023/a:1008353332208

Stroffolini, T., Andriani, A., Di Giacomo, C.

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 92 KB

english, 2000

10

10.1023/a:1008369629944

Clarke, S. J., Zalcberg, J., Olver, I., Mitchell, P. L. R., Rischin, D., Dalley, D., Green, M., Egan Davidson, Y.

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 320 KB

english, 2000

11

10.1023/a:1008356017611

Chester, J. D., Dent, J. T., Wilson, G., Ride, E., Seymour, M. T.

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 263 KB

english, 2000

12

10.1023/a:1008344014518

Fizazi, K., Zelek, L.

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 2.09 MB

english, 2000

13

US relaxes pressure on developing countries regarding medications

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 5.83 MB

english, 2000

14

WTO agreement could have threatened European health structures

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 5.83 MB

english, 2000

15

Progress in euthanasia in Switzerland and Belgium

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 5.83 MB

english, 2000

16

Perhaps not everyone knows that...

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 5.83 MB

english, 2000

17

This letter was referred to the authors, who respond as follows:: A new strategy in unresectable metastatic colorectal cancers

Giacchetti, S., Levi, F.

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 221 KB

english, 2000

18

10.1023/a:1008327527877

Verweij, J.

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 188 KB

english, 2000

19

10.1023/a:1008373101913

Zanetta, G.

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 66 KB

english, 2000

20

10.1023/A:1008369812295

Greco, F. A., Erland, J. B., Morrissey, L. H., Burris III, H. A., Hermann, R. C., Steis, R., Thompson, D., Gray, J., Hainsworth, J. D.

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 591 KB

english, 2000

21

A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer

Di Leo, A., Crown, J., Nogaret, J.-M., Duffy, K., Bartholomeus, S., Dolci, S., Rowan, S., O'Higgins, N., Paesmans, M., Larsimont, D., Riva, A., Piccart, M. J.

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 681 KB

english, 2000

22

Low-dose continuous oral fosfestrol is highly active in 'hormone-refractory' prostate cancer

Orlando, M., Chacón, M., Salum, G., Chacón, D. R.

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 463 KB

english, 2000

23

Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials

Bachelot, T., Ray-Coquard, I., Catimel, G., Ardiet, C., Guastalla, J. P., Dumortier, A., Chauvin, F., Droz, J. P., Philip, T., Clavel, M.

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 512 KB

english, 2000

24

l-asparagine depletion and l-asparaginase activity in children with acute lymphoblastic leukemia receiving i.m. or i.v. Erwinia C. or E. colil-asparaginase as first exposure

Rizzari, C., Zucchetti, M., Conter, V., Diomede, L., Bruno, A., Gavazzi, L., Paganini, M., Sparano, P., Lo Nigro, L., Aricò, M., Milani, M., D'lncalci, M.

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 450 KB

english, 2000

25

Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma

Morant, R., Bernhard, J., Maibach, R., Borner, M., Fey, M. F., Thürlimann, B., Jacky, E., Trinkler, F., Bauer, J., Zulian, G., Hanselmann, S., Hürny, C., Hering, F.

Journal:

Annals of Oncology

Year:

2000

File:

PDF, 588 KB

2000

26

Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma

Morant, R., Bernhard, J., Maibach, R., Borner, M., Fey, M. F., Thürlimann, B., Jacky, E., Trinkler, F., Bauer, J., Zulian, G., Hanselmann, S., Hürny, C., Hering, F.

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 588 KB

english, 2000

27

Randomised phase II study of cisplatin-etoposide versus infusional carboplatin in advanced non-small-cell lung cancer and mesothelioma

White, S.C., Anderson, H., Jayson, G.C., Ashcroft, L., Ranson, M., Thatcher, N.

Journal:

Annals of Oncology

Year:

2000

File:

PDF, 583 KB

2000

28

Acute myelogenous leukaemia and myelomonocytic blast crisis following polycytemia vera in HIV positive patients: Report of cases and review of the literature

Hentrich, M., Rockstroh, J., Sandner, R., Brack, N., Hartenstein, R.

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 495 KB

english, 2000

29

New drugs meeting in Washington: Too demanding for clinicians?

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 1.88 MB

english, 2000

30

Second-line chemotherapy with weekly oxaliplatin and high-dose 5-fluorouracil with folinic acid in metastatic colorectal carcinoma: A Hellenic Cooperative Oncology Group (HeCOG) phase II feasibility study

Janinis, J., Papakostas, P., Samelis, G., Skarlos, D., Papagianopoulos, P., Fountzilas, G.

Journal:

Annals of Oncology

Year:

2000

Language:

english

File:

PDF, 2.15 MB

english, 2000

31

Book review

Timothy, A.

Journal:

Annals of Oncology

Year:

2000

File:

PDF, 116 KB

2000

32

Second-line chemotherapy with weekly oxaliplatin and high-dose 5-fluorouracil with folinic acid in metastatic colorectal carcinoma: A Hellenic Cooperative Oncology Group (HeCOG) phase II feasibility study

Janinis, J., Papakostas, P., Samelis, G., Skarlos, D., Papagianopoulos, P., Fountzilas, G.

Journal:

Annals of Oncology

Year:

2000

File:

PDF, 2.15 MB

2000

33

Contents of the next issue

Journal:

Annals of Oncology

Year:

2000

File:

PDF, 109 KB

2000

34

Volume 11; Issue 2

Medical errors kill more than does breast cancer

Agreement over paclitaxel reinforces BMS monopoly

Amid growing inequalities, an invitation to act

10.1023/a:1008398116335

10.1023/a:1008358411251

10.1023/a:1008325110921

10.1023/a:1008372404504

10.1023/a:1008382030802

10.1023/a:1008353332208

10.1023/a:1008369629944

10.1023/a:1008356017611

10.1023/a:1008344014518

US relaxes pressure on developing countries regarding medications

WTO agreement could have threatened European health structures

Progress in euthanasia in Switzerland and Belgium

Perhaps not everyone knows that...

This letter was referred to the authors, who respond as follows:: A new strategy in unresectable metastatic colorectal cancers

10.1023/a:1008327527877

10.1023/a:1008373101913

10.1023/A:1008369812295

A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer

Low-dose continuous oral fosfestrol is highly active in 'hormone-refractory' prostate cancer

Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials

l-asparagine depletion and l-asparaginase activity in children with acute lymphoblastic leukemia receiving i.m. or i.v. Erwinia C. or E. colil-asparaginase as first exposure

Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma

Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma

Randomised phase II study of cisplatin-etoposide versus infusional carboplatin in advanced non-small-cell lung cancer and mesothelioma

Acute myelogenous leukaemia and myelomonocytic blast crisis following polycytemia vera in HIV positive patients: Report of cases and review of the literature

New drugs meeting in Washington: Too demanding for clinicians?

Second-line chemotherapy with weekly oxaliplatin and high-dose 5-fluorouracil with folinic acid in metastatic colorectal carcinoma: A Hellenic Cooperative Oncology Group (HeCOG) phase II feasibility study

Book review

Second-line chemotherapy with weekly oxaliplatin and high-dose 5-fluorouracil with folinic acid in metastatic colorectal carcinoma: A Hellenic Cooperative Oncology Group (HeCOG) phase II feasibility study

Contents of the next issue

Table of Contents